IRIS
CHITI, ARTURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.431
AS - Asia 2.527
EU - Europa 2.214
SA - Sud America 721
AF - Africa 393
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 6
Totale 17.306
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.208
SG - Singapore 1.339
BR - Brasile 667
CN - Cina 656
FI - Finlandia 549
IE - Irlanda 399
NG - Nigeria 349
DE - Germania 287
IT - Italia 216
CA - Canada 182
FR - Francia 174
IN - India 140
NL - Olanda 125
SE - Svezia 125
GB - Regno Unito 122
TR - Turchia 97
HK - Hong Kong 65
IL - Israele 57
RU - Federazione Russa 54
BE - Belgio 52
BD - Bangladesh 30
IQ - Iraq 26
AR - Argentina 18
ES - Italia 18
MX - Messico 17
PL - Polonia 16
ZA - Sudafrica 16
JP - Giappone 15
VN - Vietnam 14
AT - Austria 13
IR - Iran 13
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 10
EC - Ecuador 10
UA - Ucraina 10
JM - Giamaica 9
KE - Kenya 9
PK - Pakistan 9
SA - Arabia Saudita 9
CL - Cile 8
EU - Europa 8
KG - Kirghizistan 8
MA - Marocco 8
TW - Taiwan 8
EE - Estonia 5
PA - Panama 5
RO - Romania 5
UY - Uruguay 5
AU - Australia 4
CH - Svizzera 4
EG - Egitto 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CO - Colombia 3
HR - Croazia 3
KZ - Kazakistan 3
LT - Lituania 3
MT - Malta 3
NI - Nicaragua 3
NP - Nepal 3
PE - Perù 3
PH - Filippine 3
TH - Thailandia 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SC - Seychelles 2
TN - Tunisia 2
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GI - Gibilterra 1
HU - Ungheria 1
ID - Indonesia 1
IS - Islanda 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
Totale 17.300
Salva come PNG Salva come JPEG
Città #
Wilmington 2.010
Chandler 1.882
San Mateo 776
The Dalles 676
Singapore 660
Ann Arbor 609
Helsinki 545
Shanghai 529
Leawood 401
Dublin 398
Boardman 354
Benin City 348
Ashburn 332
Lawrence 327
Princeton 327
New York 199
Fairfield 195
Woodbridge 181
Toronto 163
Paris 161
Amsterdam 113
Pune 97
Kocaeli 80
London 80
Milan 79
Seattle 72
São Paulo 59
San Diego 57
Brussels 51
Norwalk 49
Santa Clara 46
Los Angeles 45
Monmouth Junction 44
Hong Kong 39
Munich 35
Beijing 32
Falls Church 30
Moscow 30
Phoenix 25
Rio de Janeiro 24
Belo Horizonte 17
Brooklyn 17
Houston 17
Redmond 15
Redwood City 14
Warsaw 13
Campinas 12
Atlanta 11
Brasília 11
Cambridge 11
Council Bluffs 11
Dhaka 11
Falkenstein 11
Des Moines 10
Johannesburg 10
Naples 10
Osasco 10
Zhengzhou 10
Berlin 9
Chicago 9
Columbus 9
Dallas 9
Porto Alegre 9
San Francisco 9
Tappahannock 9
Curitiba 8
Düsseldorf 8
Erbil 8
Kingston 8
Ribeirão Preto 8
Terracina 8
Tokyo 8
Vienna 8
Abbiategrasso 7
Andover 7
Bishkek 7
Boston 7
Brno 7
Chennai 7
Florence 7
Mumbai 7
Uberlândia 7
Augusta 6
Baghdad 6
Charlotte 6
Fortaleza 6
Goiânia 6
Jacksonville 6
Nairobi 6
Portsmouth 6
Reston 6
San Jose 6
Buffalo 5
Contagem 5
Frankfurt am Main 5
Hangzhou 5
Hanover 5
Joinville 5
Lauterbourg 5
Manchester 5
Totale 12.671
Salva come PNG Salva come JPEG
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 131
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer. 118
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer 108
11Cl-choline PET/CT in imaging locally advanced prostate cancer 108
Applications of PET imaging with radiolabelled choline (C-11/F-18-choline) 92
18F-FDG PET and CT scan in the pre-operative evaluation of colorectal liver metastases treated with chemotherapy 89
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 87
A portrait of the scientist as a young woman Comments after the first EANM Young Investigators' Meeting 86
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 86
18F-FDG pet does not improve contrast enhanced CT scan sensitivity in the evaluation of liver metastases after chemotherapy 84
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 83
[F-18] FDG PET/CT features for the molecular characterization of primary breast tumors 82
Carbon-11-methionine PET-CT as an imaging biomarker in brain gliomas eligible for surgery 80
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy 79
A case of metastatic axillary lymph nodes involvement from unknown primary cancer: Clinical usefulness of [Tc-99m]-sestamibi 79
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 78
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 76
Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study 76
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 75
A DOUBTFUL IMAGE OF LEVEEN SHUNT PATENCY 75
I-131/I-123-Metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging 72
PREDICTIVE VALUE OF EARLY PET DURING SALVAGE CHEMOTHERAPY IN RELAPSING/REFRACTORY HODGKIN'S LYMPHOMA (HL) PATIENTS 71
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 71
A risk management approach for imaging biomarker-driven clinical trials in oncology 71
Imaging of neuroendocrine tumours with gamma-emitting radiopharmaceuticals 70
C-11-Methionine uptake in secondary brain epilepsy 70
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 70
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer 70
F-18-DOPA PET/CT in Neuroblastoma Comparison of Conventional Imaging With CT/MR 69
Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases 68
A case of atypical giant cell arteritis diagnosed by positron emission tomography (PET) 68
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 68
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 68
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 68
Evaluation of response: is F-18-FDG PET the answer? 67
INDIUM-111-DTPA-OCTREOTIDE SCINTIGRAPHY MODULATION BY TREATMENT WITH UNLABELED SOMATOSTATIN ANALOG IN SMALL-CELL LUNG-CANCER 67
Role of I-131-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours - Experience of the National Cancer Institute of Milan 67
A method to reduce acetonitrile amount in F-18-FDG synthesis 67
Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can positron emission tomography (PET) with F-18-FDG be considered as the best method? 66
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 66
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 66
Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy 66
Clinical implications of immunohistochemical assessment of somatostatin receptors subtype 2 and 5 in the diagnostic and therapeutic management of gastro-entero-pancreatic neuroendocrine tumours 66
Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail 65
The Path to the Future: Education of Nuclear Medicine Therapeutic Specialists as Responsible Physicians 65
Correlation of microvascular fractal dimension with positron emission tomography [C-11]-methionine uptake in glioblastoma multiforme: Preliminary findings 65
Assessment of tumor response in malignant pleural mesothelioma 65
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy 65
The 2015 Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma: the "evidence-based" refusal to endorse them by EANM due to the "not evidence-based" marginalization of the role of Nuclear Medicine 65
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 65
Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572-83 64
PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014 64
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 64
Pancreatic cancer or chronic pancreatitis? An answer from PET/MRI image fusion 63
Radiopharmaceuticals for breast cancer imaging 63
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems 63
Multimodal Characterization of Supratentorial Gliomas: Relationship Among Morphological, Metabolic and Molecular features 63
Molecular Imaging in Radiotherapy Planning for Head and Neck Tumors 63
[C-11] Choline PET/CT Impacts Treatment Decision Making in Patients With Prostate Cancer Referred for Radiotherapy 63
Prognostic significance of molecular and imaging biomarkers in primary brain tumors 62
EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma 62
Chest CT in patients with a moderate or high pretest probability of COVID-19 and negative swab 62
SEGMENTAL FDG-PET/CT IN SOLITARY PULMONARY NODULE: PRELIMINARY DATA OF THE PET ITALIAN TRIAL 61
F-18-FDG PET/CT scans for children and adolescents 61
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 61
CASE-REPORT - TECHNETIUM-99M-HEXAKIS-2-METHOXY-ISOBUTYL-ISONITRILE IMAGING OF BREAST-CANCER AND MYOCARDIAL-INFARCTION IN THE SAME PATIENT 61
C-11-labeled methionine and evaluation of malignant pleural mesothelioma 60
Assessment of mediastinal involvement in lung cancer with technetium-99m-sestamibi SPECT 60
New Clinical Indications for F-18/C-11-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature 60
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 60
Standardization and quantification in PET/CT imaging: tracers beyond FDG. 60
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 60
Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning 60
Diagnostic accuracy of C-11-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinoma 60
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 60
Exploration of Disease Markers under Translational Medicine Model 59
PRELIMINARY-RESULTS OF PREOPERATIVE AXILLARY RADIOIMMUNOSCINTIGRAPHY WITH IN-111 B72.3 IN BREAST-CANCER 59
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology 59
Endorsement of International Consensus Radiochemistry Nomenclature Guidelines 59
FDG-PET as a tool to optimize residual surgery in patients with primary extragonadal germ cell tumors: preliminary results 59
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 59
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma 59
FDG PET/CT predictive role in follicular lymphoma 58
Procedure guidelines for PET/CT tumour imaging with Ga-68-DOTA-conjugated peptides: Ga-68-DOTA-TOC, Ga-68-DOTA-NOC, Ga-68-DOTA-TATE 58
The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors | [La scintigrafia dei recettori per la somatostatina nei tumori neuroendocrini gastro-entero-pancreatici.] 58
Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma 58
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 58
Prognostic and predictive role of [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy 58
Consensus on molecular imaging and theranostics in prostate cancer 58
Utility of gallium-67 in determining the radicality of lymph node dissections of the neck for metastatic lymph nodes with extranodal spread in patients affected by carcinoma of the head and neck 58
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 58
Axillary node metastasis detection in breast cancer with Tc-99m-sestamibi and In-111-pentetreotide 58
Advanced Imaging Supports the Mechanistic Role of Autoimmunity and Plaque Rupture in COVID-19 Heart Involvement 57
Nuclear medicine procedures in lung cancer 57
Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer 57
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 57
Why New Journals? The Growth of the EJNMMI Family 57
Prone scintimammography in patients with non-palpable breast lesions 57
In-111-pentetreotide scintigraphy: procedure guidelines for tumour imaging 56
Cardiac and Acoustic Metastases in Relapsing Melanoma 56
Totale 6.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.889 38 50 45 17 37 1.227 544 278 734 501 38 380
2021/20221.919 161 17 62 414 37 28 73 260 161 129 486 91
2022/20235.106 748 197 462 560 456 462 10 410 947 432 344 78
2023/20242.627 220 320 583 174 63 301 150 129 51 35 240 361
2024/20253.436 90 71 28 42 62 431 195 380 435 888 414 400
2025/2026474 474 0 0 0 0 0 0 0 0 0 0 0
Totale 17.471